CAPTRUST Financial Advisors
COCP icon

CAPTRUST Financial Advisors’s Cocrystal Pharma COCP Stock Holding History

CAPTRUST Financial Advisors’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-192
Closed -$1K – 2445
2022
Q2 		$1K Hold
192
– – ﹤0.01% 4650
2022
Q1 		$1K Buy
192
+167
+668% +$1.11K ﹤0.01% 4669
2021
Q4 		$0 Buy
25
+3
+14% +$31 ﹤0.01% 4779
2021
Q3 		$0 Hold
22
– – ﹤0.01% 4656
2021
Q2 		$0 Hold
22
– – ﹤0.01% 4534
2021
Q1 		$0 Sell
22
-334
-94% -$6.78K ﹤0.01% 4388
2020
Q4 		$6K Hold
356
– – ﹤0.01% 2761
2020
Q3 		$4K Hold
356
– – ﹤0.01% 2578
2020
Q2 		$6K Buy
+356
New +$4.36K ﹤0.01% 2335
2019
Q4 		– Sell
-56
Closed -$1K – 1152
2019
Q3 		$1K Hold
56
– – ﹤0.01% 1852
2019
Q2 		$2K Buy
+56
New +$1.66K ﹤0.01% 1790

Other funds holding COCP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CAPTRUST Financial Advisors's COCP Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Cocrystal Pharma (COCP) in Q3 2022, closing a stake of 192 shares — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in COCP in Q2 2019 and held it in 11 quarters. The position peaked at $6K in Q4 2020. 27 funds tracked by Wall St. Rank hold COCP as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Cocrystal Pharma position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 192 Cocrystal Pharma shares in Q3 2022, an estimated $1K.
  • CAPTRUST Financial Advisors first reported a position in Cocrystal Pharma in Q2 2019 and held it in 11 quarters.
  • CAPTRUST Financial Advisors's Cocrystal Pharma position peaked at $6K in Q4 2020.
  • 27 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.